Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925114 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of S-309309 in Obese Adults
A Phase 2 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 2
- Development phase
- 365
- Enrollment target
NCT05925114 is a Phase 2 study that has completed, run by Shionogi. The registered enrollment target is 365 participants.
The verdict
NCT05925114, a Phase 2 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 365 participants
- Enrollment target
Study Summary
The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.
Interventions
- DRUG Placebo
- DRUG S-309309
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2023-06-21 |
| Est. Completion | 2024-05-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05925114
The ClinicalTrials.gov registry entry for NCT05925114 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05925114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05925114 about?
NCT05925114 is a clinical study titled "Safety and Efficacy Study of S-309309 in Obese Adults". The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.
What is the current status of trial NCT05925114?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 365 participants. The study started on 2023-06-21. Estimated completion is 2024-05-17.
What interventions are being tested in trial NCT05925114?
The interventions under investigation include: Placebo (DRUG), S-309309 (DRUG).
Who is sponsoring clinical trial NCT05925114?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.